Your session is about to expire
Coreg vs Zebeta
Introduction
In managing cardiovascular conditions such as hypertension or heart failure, certain medications that influence the function and behavior of the heart can significantly help in stabilizing blood pressure and improving cardiac output. Coreg and Zebeta are two such drugs commonly prescribed for these conditions. Each of them influences different aspects of cardiac activity but both contribute to overall cardiovascular health management. Coreg is classified as a non-selective beta blocker as well as an alpha-1 blocker, affecting both the heart rate and blood vessels' constriction levels respectively. On the other hand, Zebeta specifically falls under selective beta-1 blockers category which primarily slows down the heartbeat thereby reducing blood pressure effectively.
Coreg vs Zebeta Side By Side
| Attribute | Coreg | Zebeta |
|---|---|---|
| Brand Name | Coreg | Zebeta |
| Contraindications | Should not be taken with or recently after using an MAO inhibitor. May worsen symptoms of certain underlying health conditions like chest pain, shortness of breath, slow or irregular heartbeat. | Should not be taken with or recently after using an MAO inhibitor. May exacerbate symptoms of certain health conditions. |
| Cost | For brand name: around $150 for 60 tablets of 6.25 mg. For generic (carvedilol): ranges from $0.08 to $1 per day depending on pack size and dosage. | For brand name: around $90 for 30 tablets of 5 mg. For generic (bisoprolol): starts from a few cents up to about half a dollar per day based on pack size and daily dosage requirements. |
| Generic Name | Carvedilol | Bisoprolol |
| Most Serious Side Effect | Allergic reactions, visual disturbances, heart-related issues, low sodium levels. | Signs of an allergic reaction, slow or uneven heartbeats, sudden shortness of breath, severe skin reactions. |
| Severe Drug Interactions | MAO inhibitors. | MAO inhibitors. |
| Typical Dose | 3.125–50 mg twice a day, with a maximum dosage of 100 mg/day. | 5 mg/day, can be increased to 10 mg/day, with a maximum of 20 mg/day. |
What is Coreg?
Carvedilol (the generic name for Coreg) is a beta blocker that functions by blocking particular responses in the body to nerve impulses, slowing down the heart rate and reducing blood pressure. It was first approved by the FDA in 1995. Coreg works on alpha and beta receptors of the nervous system which reduces workload on your heart, helping it to beat more regularly and with less force. It's prescribed primarily for treating mild to severe congestive heart failure and high blood pressure.
On the other hand, Bisoprolol fumarate (Zebeta) is another type of beta-blocker which only works on beta receptors. Zebeta mainly targets reduced heartbeat rates making it particularly beneficial for patients suffering from hypertension or angina pectoris while exhibiting fewer side effects related to lung congestion compared to non-specific beta blockers like Coreg.
What conditions is Coreg approved to treat?
Coreg is approved for the management of different cardiovascular conditions:
- Heart failure, to reduce the risk of death and hospitalization
- Hypertension, either alone or in combination with other medications
- Left ventricular dysfunction following a heart attack, to improve survival
How does Coreg help with these illnesses?
Coreg (Carvedilol) works to manage hypertension and heart failure by decreasing the rate at which the heart beats and reducing blood vessel contraction in the heart, brain, and throughout the body. It does this by blocking beta-adrenergic receptors in these organs, preventing adrenaline from making contact with these sites. This helps to decrease blood pressure, improve blood flow, and reduce strain on cardiac function. Adrenaline is a hormone and neurotransmitter that plays a crucial role in the body's fight or flight response.
On the other hand, Zebeta (Bisoprolol) also manages high blood pressure but it selectively blocks only one type of beta receptor called β1-receptors predominantly located in cardiac muscle tissue. By doing so, Zebeta slows down your heartbeat allowing for more efficient functioning of your heart while causing fewer side effects than non-selective beta blockers like Coreg.
Individuals with hypertension can have relatively high levels of stress hormones such as adrenaline resulting in increased heart rate and vasoconstriction leading to higher blood pressure. Therefore, by blocking adrenaline’s effect on β-receptors both Carvedilol & Bisoprolol limit negative effects associated with elevated BP thereby helping patients manage their condition.
What is Zebeta?
Zebeta, also known by its generic name bisoprolol, is a beta-blocker which blocks the action of certain natural chemicals in your body, such as epinephrine, on the heart and blood vessels. This effect lowers heart rate, blood pressure and strain on the heart. Zebeta was first approved by the FDA in 1992.
As Zebeta is not an alpha-beta blocker like Coreg (carvedilol), it doesn't block alpha receptors that are found on certain cells of your muscles lining arteries and veins. Its selective action means that it chiefly works to lower high blood pressure (hypertension) and help prevent strokes, kidney problems and heart attacks. The side-effect profile of Zebeta also differs from that of Coreg; while all medications can cause side effects, many people have none or minor ones with bisoprolol use. Commonly reported side effects include tiredness and reduced ability to exercise might occur due to its primary function - lowering high blood pressure.
What conditions is Zebeta approved to treat?
Zebeta, known generically as bisoprolol, is authorized for use in managing two primary conditions:
- Hypertension (high blood pressure)
- Heart failure
It's a beta-blocker that efficiently slows the heart rate and lowers blood pressure by reducing the workload on your heart. It's also used off-label to prevent migraines and relieve symptoms of anxiety.
How does Zebeta help with these illnesses?
Zebeta, or bisoprolol, is a beta-blocker which works by inhibiting the action of certain hormones like adrenaline on the heart and blood vessels. This reduces heart rate, blood pressure, and strain on the heart. Zebeta's primary function is to regulate heartbeat in conditions such as hypertension (high blood pressure), angina (chest pain), and after acute myocardial infarction (heart attack). It is more selective than Coreg - it primarily affects only one type of beta receptor thereby reducing potential side effects related to bronchoconstriction or glucose metabolism. Similar to how Wellbutrin targets norepinephrine levels for depression treatment without significantly affecting serotonin levels; Zebeta specifically targets these beta-1 receptors without significantly impacting other areas of hormonal regulation. Thus, it might be chosen over Coreg when patients exhibit specific symptoms or have accompanying health issues that require this level of selectivity.
How effective are both Coreg and Zebeta?
Both carvedilol (Coreg) and bisoprolol (Zebeta) have proven track records in managing cardiac conditions such as hypertension and heart failure, with their approvals by the FDA only a few years apart. Since they belong to different subclasses of beta-blockers, they may be prescribed under distinct circumstances. The effectiveness of carvedilol and bisoprolol in managing symptoms of heart failure was directly studied in a double-blind clinical trial in 2003; both drugs showed similar efficacy in controlling heart rate and improving left ventricular ejection fraction.
A 2011 review based on meta-analysis reports on carvedilol demonstrated that it is effective from the first week of treatment, has an acceptable side effect profile compared to other many other beta-blockers, and is well-tolerated even among elderly patients with co-existing health conditions. The same study also reported that carvedilol has become one of the most widely prescribed beta-blockers worldwide due to its unique property of blocking both beta-1 adrenergic receptors (like traditional selective beta-blockers such as bisoprolol), as well as alpha-1 adrenergic receptors.
On the other hand, a 2016 review indicated that bisoprolol appears more effective than placebo at reducing blood pressure and preventing cardiovascular events when used for long-term management of hypertension or mild heart failure. Notably though, bisoprolol is usually considered after diuretics or calcium channel blockers are deemed ineffective or unsuitable for individual patient needs. Significant research involves using bisoprolol alongside ACE inhibitors so data confirming its standalone efficacy pales somewhat against that available for carvedilot. Nonetheless due to differing pharmacological profiles between them - mainly owing to Coreg's additional alpha-blocking activity - either agent could prove optimal depending upon specific patient characteristics like comorbidities including asthma/COPD where Zebeta's cardioselective profile might make it preferable over Coreg.
Find Top Clinical Trials
Choose from over 30,000 active clinical trials.
At what dose is Coreg typically prescribed?
Oral dosages of Coreg range from 3.125–50 mg twice a day, but studies have indicated that 6.25 mg twice a day is sufficient for treating high blood pressure in most people. For heart failure, the starting dose is lower at 3.125 mg twice daily and can be increased gradually if tolerated by the patient. In either case, dosage can be increased after a couple of weeks depending on patient response and tolerance to the drug therapy. The maximum dosage that should not be exceeded in any case is 100 mg/day.
On the other hand, oral dosages of Zebeta range from 5-20mg/day once daily which has been shown to effectively manage hypertension over time for many individuals. Dosage may start as low as 2.5mg per day especially for elderly patients or those with kidney disease and slowly titrated up based on patient's response to treatment while keeping an eye out for potential side effects or intolerance to medication.
It's essential when managing cardiovascular conditions such as hypertension or heart failure that individuals work closely with their healthcare provider who will assess clinical response along with monitoring potential side effects before making changes to doses of these medications.
At what dose is Zebeta typically prescribed?
Zebeta therapy usually begins with a dosage of 5 mg/day. Depending on the patient's response and tolerance, this dosage can be increased to 10 mg/day which is typically divided into two doses, spaced approximately 12 hours apart. Maximum dose administered could reach up to 20 mg/day split into two doses of 10 mg each and spaced evenly throughout the day. If there isn't a satisfactory response after several weeks at this daily intake, your healthcare provider might consider adjusting the treatment plan or testing other options.
What are the most common side effects for Coreg?
Common side effects of Coreg and Zebeta may include:
- Dizziness, lightheadedness
- Tiredness, fatigue or sleepiness/drowsiness
- Nausea, vomiting or indigestion (burning discomfort in the digestive tract)
- Diarrhea or constipation
- Slow heartbeat
- Decreased sexual ability (libido)
- Changes in sleep pattern (insomnia or abnormal dreams)
- Dry eyes
- Cold feet or hands
It's important to know that not everyone will experience these side effects but if any of them persist or worsen, you should contact your healthcare provider immediately.
Are there any potential serious side effects for Coreg?
While Coreg and Zebeta are both beta-blockers used to treat high blood pressure, they may have different side effects. Serious health problems that could potentially occur with Coreg include:
- Allergic reactions such as hives, swelling in your face or throat, difficulty breathing
- Visual disturbances including blurred vision or eye pain
- Heart-related issues like chest discomfort, rapid heartbeats (fluttering in your chest), shortness of breath, sudden dizziness
- Low sodium levels causing headache, confusion, slurred speech, severe weakness, vomiting loss of coordination or feeling unsteady.
On the other hand with Zebeta you should watch for symptoms like:
- Very stiff (rigid) muscles, high fever sweating confusion fast uneven heartbeats tremors and feelings like you might pass out.
Remember always to consult a healthcare professional if you experience any unusual symptoms while taking these medications. As everyone reacts differently to medication it's important that medical advice is personalized for each individual patient.
What are the most common side effects for Zebeta?
Zebeta, a beta-blocker like Coreg but with its own set of potential side effects, can cause:
- Dizziness or lightheadedness
- Fatigue or weakness
- Headache
- Upset stomach, nausea, diarrhea or constipation
- Cold hands or feet
- Slow heart rate (bradycardia)
- Mild itching or rash
- Decreased concentration.
It's always crucial to remember that while these are possible side effects, not every person will experience them and some may have none at all. Always consult with your healthcare provider for personalized advice based on your health status and current medications.
Are there any potential serious side effects for Zebeta?
While Zebeta is generally safe and effective in treating high blood pressure, it may cause severe side effects on rare occasions. You should contact your healthcare provider immediately if you experience symptoms such as:
- Signs of an allergic reaction: hives; difficulty breathing; swelling of your face, lips, tongue or throat
- Slow or uneven heartbeats
- Sudden shortness of breath (even with mild exertion), swelling, rapid weight gain
- Confusion, mood changes
- Severe skin reactions: fever, sore throat, burning in your eyes, skin pain followed by a red or purple skin rash that spreads (especially in the face or upper body) and causes blistering and peeling.
Any new signs of illness like feeling short of breath even with moderate exercise could indicate hidden health conditions exacerbated by Zebeta. Report any severe side effects to a medical professional promptly for proper evaluation and management.
Contraindications for Coreg and Zebeta?
Both Coreg and Zebeta, along with most other heart medications, may worsen symptoms of certain underlying health conditions. If you notice your condition worsening or an increase in chest pain, shortness of breath, slow or irregular heartbeat while taking these drugs, please seek immediate medical attention.
Neither Coreg nor Zebeta should be taken if you are already using, or have recently stopped using a monoamine oxidase (MAO) inhibitor as this can cause severe interactions. Always inform your doctor about all the medications you take; MAO inhibitors require a period of about two weeks to clear from the system to prevent hazardous interactions with both Coreg and Zebeta.
How much do Coreg and Zebeta cost?
For the brand name versions of these drugs:
- The price of 60 tablets of Coreg (6.25 mg) averages around $150, which works out to about $2.50/day, depending on your dose.
- The price of 30 tablets of Zebeta (5 mg) averages is about $90, working out to approximately $3/day.
Thus, if you are in the higher dosage range for Coreg (i.e., 25 mg/day or higher), then brand-name Zebeta could be less expensive on a per-day treatment basis. Please note that cost should not be a primary consideration in determining which of these drugs is right for you.
For the generic versions of Coreg (carvedilol) and Zebeta (bisoprolol), costs are significantly lower:
- Carvedilol is available in packs ranging from 15 to 500 tablets with approximate costs between $0.08 and $1 per day depending on pack size and dosage.
- Bisoprolol comes in packs ranging from 30 to1000 tablets with prices starting from as low as a few cents up to about half a dollar per day based on pack size and daily dosage requirements.
Popularity of Coreg and Zebeta
Carvedilol, in generic form as well as brand names like Coreg, was estimated to have been prescribed to about 8 million people in the US in 2020. Carvedilol accounted for approximately 20% of prescriptions among beta-blockers used for heart conditions and high blood pressure treatment. This drug is a unique "non-selective" beta blocker that also exhibits alpha-blocking activity.
Bisoprolol, including its brand version Zebeta, was prescribed to around 3 million individuals in the USA during the same year. In terms of overall beta-blocker prescriptions within the country, bisoprolol accounts for roughly around 7%. Bisoprolol is considered a "selective" beta-blocker mainly impacting heart rate control without significant impact on lung function. Over the past decade, there has been a steady increase in bisoprolol use due to its lower risk of exacerbating asthma or COPD symptoms compared with non-selective drugs like carvedilol.
Conclusion
Both Coreg (carvedilol) and Zebeta (bisoprolol) are well-documented in the treatment of hypertension and heart failure, with numerous clinical studies supporting their effectiveness over placebo treatments. In some instances, these medications may be used together under careful physician supervision as they can interact with each other. Due to their different modes of action - carvedilol being a non-selective beta-blocker also possessing alpha-blocking activity, while bisoprolol is a selective beta-1 adrenergic antagonist - they tend to be prescribed under varying circumstances. Carvedilol is often considered for patients who have concomitant cardiac conditions like angina or certain arrhythmias due to its mixed mechanism of action.
Both drugs have generic versions available, providing significant cost savings especially important for those paying out-of-pocket. It's worth noting that both Coreg and Zebeta may require an adjustment period; hence effects might not be immediately noticeable.
The side effect profiles are somewhat similar between the two drugs, but individual response varies greatly so close monitoring by your healthcare provider is needed when starting therapy. For both drugs, patients should seek medical help immediately if they experience severe side effects such as worsening chest pain or slow heartbeat.
Other Trials to Consider
Popular Categories
Popular Guides
Learn More About These Treatments
Refrences
- Stoschitzky, K., Stoschitzky, G., Brussee, H., Bonell, C., & Dobnig, H. (2006). Comparing Beta-Blocking Effects of Bisoprolol, Carvedilol and Nebivolol. Cardiology. S. Karger AG.http://doi.org/10.1159/000093060
- Ruffolo, R. R., & Feuerstein, G. Z. (2006, June). Carvedilol case history: the discovery and development of the first β-blocker for the treatment of congestive heart failure. Expert Opinion on Drug Discovery. Informa Healthcare.http://doi.org/10.1517/17460441.1.1.85
- Feuerstein, G. Z., & Ruffolo, R. R. (1996, April 2). Carvedilol, a novel vasodilating beta-blocker with the potential for cardiovascular organ protection. European Heart Journal. Oxford University Press (OUP).http://doi.org/10.1093/eurheartj/17.suppl_b.24